Molecular Diagnosis of Systemic Autoinflammatory Diseases

ConditionsInflammatory Disease Genetic Disease Somatic Mutation Molecular Sequence Variation Molecular Pathway Deregulation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-120

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

About this trial

Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.

Eligibility criteria

Qualifiers

A patient presenting with a clinical and biological aseptic inflammatory syndrome associating one or more of the following signs: spontaneously resolving fever, abdominal (pain, diarrhea), locomotor (arthralgia, myalgia), thoracic (pain, pericarditis), cutaneous, sensory (uveitis, deafness), or renal (amyloidosis) involvement.

Disqualifiers

Adult subject to legal protection measures (guardianship, curatorship, safeguard of justice).

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Lead sponsor

Source ClinicalTrials.gov